Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease

被引：0

作者：

Fruchart, JC

Brewer, B

Leitersdorf, E

Brochier, M

Brown, G

Calvo, C

Carmena, R

Ceska, R

Loy-Soong, WC

Davignon, J

Gotto, A

Grundy, S

Hamsten, A

Keech, A

Matsuzawa, Y

Patch, JR

Paoletti, R

Raslova, K

Smirnov, V

Steiner, G

Thompson, G

Zhu, JR

机构：

[1] Inst Pasteur, INSERM, U325, F-59019 Lille, France

[2] NHLBI, NIH, Bethesda, MD 20892 USA

[3] Hadassah Univ Hosp, Div Med, IL-91120 Jerusalem, Israel

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 81卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The hypolipidemic action of fibrates has recently been shown to involve the activation of peroxisome proliferator activated receptors establishing a molecular mechanism for this class of drugs. Increasing clinical trial evidence supports the efficacy of fibrates in the treatment of dyslipoproteinemias, particularly in patients with hypertriglyceridemia and low high-density lipoproteins.

引用

页码：912 / +

页数：7

共 50 条

[31] Surgical treatment of coronary heart disease
Gams, E
INTERNIST, 1997, 38 (01): : 64 - 72
[32] TREATMENT OF CORONARY HEART-DISEASE
ENENKEL, W
WIENER MEDIZINISCHE WOCHENSCHRIFT, 1977, 127 (20) : 624 - 627
[33] Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations
Hamilton-Craig, Ian
Kostner, Karam Maximilien
Woodhouse, Stan
Colquhoun, David
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE, 2012, 10 (03): : 181 - 190
[34] Use and misuse of dietary fatty acids for the prevention and treatment of coronary heart disease
de Lorgeril, M
Salen, P
REPRODUCTION NUTRITION DEVELOPMENT, 2004, 44 (03): : 283 - 288
[35] DYSLIPOPROTEINEMIA IN HYPERLIPIDEMIC AND NORMOLIPIDEMIC PATIENTS WITH CORONARY-ARTERY DISEASE DOCUMENTED CORONARY ANGIOGRAPHY
OKABE, M
MATUSDA, Y
MATUSDA, M
OGAWA, H
NAITO, H
KATAYAMA, K
FUJII, H
KAWANO, M
KUMADA, T
KUSUKAWA, R
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1981, 45 (08): : 872 - 872
[36] Use of coronary calcification scores to predict coronary heart disease
Pletcher, MJ
Tice, JA
Pignone, M
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (15): : 1831 - 1832
[37] Clopidogrel use in coronary heart disease and percutaneous coronary intervention
Atiemo, Andrew D.
Williarns, Marlene S.
JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (04) : 689 - 700
[38] APEXCARDIOGRAPHY - USE IN CORONARY HEART DISEASE AND REPRODUCIBILITY
GINN, WM
SHERWIN, RW
HARRISON, WK
BAKER, BM
AMERICAN HEART JOURNAL, 1967, 73 (02) : 168 - &
[39] The use of antioxidant supplements in coronary heart disease
Kritharides, L
Stocker, R
ATHEROSCLEROSIS, 2002, 164 (02) : 211 - 219
[40] CONSENSUS SYMPOSIUM - DIETARY RECOMMENDATIONS FOR THE PREVENTION OF CORONARY HEART-DISEASE
不详
SOUTH AFRICAN MEDICAL JOURNAL, 1988, 74 (09): : 475 - 476

← 1 2 3 4 5 →